Treatment Options for Symptomatic Uterine Leiomyoma

Medical Management

The American College of Radiology suggests that oral contraceptives and progestins may effectively manage bleeding symptoms, especially in women with smaller fibroids, though they have limited effect on fibroid size 1
Tranexamic acid, a non-hormonal agent, can help reduce menorrhagia associated with fibroids but may cause adverse effects such as pelvic pain and fever 1
Selective progesterone receptor modulators (SPRMs) have shown promising results in reducing fibroid volume and controlling symptoms, though more long-term studies are needed 1

Uterine Artery Embolization (UAE) has technical success in >95% of cases, resulting in 40-50% decrease in uterine volume and symptom control in approximately 80% of patients 2
Long-term follow-up shows 20-25% symptom recurrence at 5-7 years after UAE, with higher failure rates in patients <40 years of age 3, 4
Endometrial ablation is effective for abnormal uterine bleeding with >95% patient satisfaction, but has a 23% failure rate in treating patients with submucosal fibroids compared to 4% in patients with normal uterine cavities 4
MR-guided Focused Ultrasound Surgery (MRgFUS) uses high-intensity ultrasound to ablate fibroid tissue, though data on long-term outcomes and fertility after this procedure are limited 5
Laparoscopic approaches using Nd:YAG laser, bipolar needles, monopolar cautery, or cryotherapy (myolysis) can reduce fibroid volume by 40-80%, offering a promising option for women seeking uterus-preserving treatment 6

Hysterectomy is the definitive treatment for symptomatic fibroids with up to 90% of patients reporting at least moderate satisfaction 2 years after the procedure 4
Myomectomy is appropriate for women wishing to preserve fertility, with recurrence rates of approximately 27% at 10 years and higher rates in women with multiple fibroids 6, 1
Laparoscopic myomectomy is associated with 2% major complication and 9% minor complication rates 1

Location of fibroids significantly impacts treatment success - cervical fibroids and multiple submucosal fibroids have higher treatment failure rates with UAE 4, 3
Age impacts treatment outcomes - UAE has higher failure rates in women <40 years, likely due to increased collateral vessel recruitment 3
Pedunculated subserosal fibroids were previously considered a contraindication to UAE due to concerns about fibroid detachment, but recent studies show good outcomes without complications 5
For women with coexisting adenomyosis, UAE has shown early success in controlling bleeding symptoms with long-term symptomatic relief ranging from 65% to 88% 5
When fibroids coexist with endometriosis, surgical methods addressing both conditions simultaneously may be more appropriate 5

Uterine fibroids are the most common benign tumors in women of reproductive age, with up to 70% of women developing them by age 50, though only 20-50% become symptomatic 7
Common symptoms include abnormal uterine bleeding, pelvic pain/pressure, dysmenorrhea, reproductive failure, and compression of adjacent pelvic organs 7, 8
Fibroids can be classified by location as subserosal, intramural, or submucosal, which affects both symptoms and treatment approach 9

The American College of Radiology recommends that GnRH agonists effectively reduce fibroid volume by 35% and improve hemoglobin levels but cause significant hypoestrogenic side effects 10
Add-back therapy with GnRH agonists mitigates hypoestrogenic side effects while maintaining therapeutic efficacy 11

Uterine Artery Embolization (UAE) is an effective alternative to surgery with technical success in >95% of cases 9
UAE results in 40-50% decrease in uterine volume and symptom control in approximately 80% of patients 9
Laparoscopic approaches using Nd:YAG laser, bipolar needles, monopolar cautery, or cryotherapy can reduce fibroid volume by 40-80% 9
Myolysis techniques represent a promising option for women seeking uterus-preserving treatment 12, 9

Myomectomy is appropriate for women who wish to preserve fertility or their uterus 7
Recurrence risk is approximately 27% at 10 years, with higher rates in women with multiple fibroids 9
Women should wait 2-3 months after myomectomy before attempting pregnancy to allow proper healing 10
Hysterectomy is the most effective and definitive treatment for symptomatic fibroids with high satisfaction rates 13

Intramural fibroids negatively affect fertility, but treating asymptomatic fibroids does not necessarily improve fertility outcomes 9
GnRH agonist therapy without add-back results in approximately 1% bone loss per month and should not be used long-term 10, 11

The American College of Radiology recommends that MR-guided High-Intensity Focused Ultrasound (MRgFUS/HIFU) achieves approximately 50% fibroid volume reduction at 1 year and 40% reduction at 24 months, but viable tumor cells persist in 26% of specimens after treatment 14, 15
HIFU is currently restricted to patients meeting specific criteria, including fewer than 6 leiomyomas 15 and total fibroid volume <900 cm³ 14
The procedure is noninvasive but time-intensive, with each treatment session taking several hours to complete 14, 15

The American College of Radiology states that the evidence for HIFU in women desiring pregnancy is severely limited and concerning, with only 41% of pregnancies resulting in live births 14, 15, 16
Registry data shows that 28% of pregnancies ended in spontaneous abortion, nearly double the general population rate 14
The American College of Radiology recommends that for reproductive-age patients with fibroids desiring pregnancy, laparoscopic or open myomectomy should be offered as the first therapeutic choice 16

Myomectomy has pregnancy rates of 85% and live birth rates of 65%, compared to HIFU's 41% live birth rate 16
Uterine Artery Embolization (UAE) should not be first-line in women seeking pregnancy, due to increased miscarriage and cesarean section rates 14, 15

For reproductive-age women with intramural myomas, the American College of Radiology recommends offering laparoscopic or open myomectomy as first-line if fertility is desired 16
HIFU may be considered in specific scenarios, including poor surgical candidates or patients who refuse surgery despite counseling 14, 15, 16